Neoplasia/BPH

	Exploring the potential mechanisms of hydroquinone on bladder cancer using network toxicology, Mendelian randomization analysis, molecular docking, and molecular dynamics simulations. Discov Oncol Li Y, Ma Y, Lai J, Wan Q, Li J, Wu J. PMID: 41758391 [PubMed - as supplied by publisher]
	External validation and comparison of nomograms for prediction of long-term disease recurrence and survival for bladder cancer patients who undergo radical cystectomy. Minerva Urol Nephrol Benijts R, Akand M, Tipirdamaz M, Mennes J, Baekelandt L, Everaerts W, Albersen M, VAN Poppel H, Joniau S, VAN DER Aa F. PMID: 41757874 [PubMed - as supplied by publisher]
	Comparative Study of Chemically Induced Renal Mesenchymal and Mammary Tumors in Female Sprague-Dawley and Wistar Rats. Toxicol Pathol Duarte MCO, Oliveira ISQ, Romualdo GR, Rodrigues MAM, da Silva TC, Cogliati B, Barbisan LF. PMID: 41757734 [PubMed - in process]
	Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST). BJU Int Malpani A, Ryan JT, Yu H, Soodana-Prakash N, Khandekar A, Ajami T, Williams A, Szczotka Z, Alshalalfa M, Hao Y, Davicioni E, Swain S, Kryvenko O, Pra AD, Stoyanova R, Gaston S, Pollack A, Mahal BA, Abramowitz M, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 41757539 [PubMed - as supplied by publisher]
	A rare case of ectopic cushing's syndrome caused by renal neuroendocrine tumor. J Diabetes Metab Disord Sehatpour F, Panahi N, Ramezani-Binabaj M, Yahyazadeh SR, Sefidbakht S, Tavangar SM, Manafi-Farid R, Soltani A, Radmard AR, Mirtaher FS, Pejman Sani M, Sajjadi-Jazi SM. PMID: 41757383 [PubMed]
	Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro). ESMO Real World Data Digit Oncol Anton A, Steer C, Arasaratnam M, Torres J, Weickhardt A, Warren M, Mislang ARA, Azad AA, Linton A, Smith A, Rai S, Hong W, Gibbs P, Tran B. PMID: 41757352 [PubMed]
	Progression-Free Survival versus Overall Survival in Patients with PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP versus Placebo. Res Sq McNeel D, Eickhoff J, Perez A, Liu G. PMID: 41756446 [PubMed]
	Comparison of image quality between simultaneous multi-slice single-shot EPI and readout-segmented EPI in diffusion-weighted imaging of prostate cancer: a retrospective study. Front Oncol Zhang T, Chen J, Li M, Shen A. PMID: 41756317 [PubMed]
	Developing an interpretable clinical-radiomics machine learning model using whole transition zone MRI analysis for improving diagnosis of transition zone prostate cancer. Front Oncol Yang J, Jiang N, Zhang Y, Yang L, Xia L, Ren Y, Xu H, Li Z, Wang J, Cui F. PMID: 41756314 [PubMed]
	The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. Front Immunol Yu M, Zhou D, Wei H, Wu T, Fan J, Ran G, Zhang C. PMID: 41756279 [PubMed - in process]
	Pancreatic Metastases from Clear Cell Renal Cell Carcinoma: Diagnostic Insights from Endoscopic Ultrasound-Guided Fine-Needle Biopsy. Medicina (Kaunas) Constantinescu A, Dina I, Nedelcu M, B, Florescu V, Enache L, Andronic O, Voiculescu D, N. PMID: 41752639 [PubMed - in process]
	Integration of Bulk and Single-Cell Transcriptomics Reveals Prognostic and Immunological Roles of MTHFD2 in Clear Cell Renal Cell Carcinoma. Int J Mol Sci Zhou Y, Zheng X, Ye P, Yang H. PMID: 41752156 [PubMed - in process]
	PD-L1 Expression in Prostate Cancer: Anatomopathological Features, Methodological Pitfalls, and Therapeutic Potential. Int J Mol Sci Pepe L, Pizzimenti C, Tralongo P, Zuccalà V, Ieni A, Pepe P, Ricciardi G, Cianci V, Mondello C, Martini M, Fadda G, Fiorentino V. PMID: 41751934 [PubMed - in process]
	Gene Expression-Guided Drug Repurposing in Oncology: Insights from Antiretroviral Agents in Prostate and Bladder Cancer. Genes (Basel) Pereira M, Vale N. PMID: 41751568 [PubMed - in process]
	Genomic Subtypes and Computational Biomarkers in Non-Muscle-Invasive Bladder Cancer Guiding Optimal Timing of Radical Cystectomy and BCG Response Prediction. Genes (Basel) Schi, Munteanu VC, Borz MB, Cojocaru I, Morari O, Gîrbovan M, Ti. PMID: 41751537 [PubMed - in process]
	Identification of Paraptosis-Related Renal Cell Carcinoma Subtypes, Construction of a Prognostic Signature, and Determination of Tumor Microenvironment Landscape Using Bioinformatic Analysis and Experimental Verification. Curr Issues Mol Biol Qin M, Chen M, Gan Y, Feng X, Huang P, Meng F, Yang Y. PMID: 41751495 [PubMed]
	Focusing on Prostate-Specific Membrane Antigen in Precision Diagnosis and Treatment of Prostate Cancer. Biomedicines Ren X, Zhang L, An R, Song H, Shi M, Wang Z. PMID: 41751381 [PubMed]
	Impact of Adaptive Radiation Therapy on Toxicity in Prostate Cancer: A Scoping Review. Biomedicines Li M, Ching JCF, Tong JT, Man JYK, Hung RHM, Leung VWS, Ng CKC. PMID: 41751269 [PubMed]
	Metabolic Messengers: Extracellular Vesicles as Central Mediators of Metabolic Reprogramming in Renal Cell Cancer. Biomedicines Meng Q, Huang L, Chen Z, Lin R, Zhou X, Yang G. PMID: 41751181 [PubMed]
	A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder Cancer. Antioxidants (Basel) Parada D, Onoiu AI, Iftimie S, Camps J, Riu F, Castro A, Joven J. PMID: 41750579 [PubMed]

Articles 1 - 20 / 185853

Page 1 of 9293



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy